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This research is organized into three integrated studies that explored differences
in screening and treatment services across the cancer care continuum by race and
ethnicity. The Andersen Behavioral Model of Health Services Use and the Five
Dimensions of Access were used as conceptual frameworks. In the first study (Chapter
2), data from the Medical Expenditure Panel Survey were used to examine breast and
cervical cancer screening rates before and during the Great Recession (2007-2009). The
interaction terms of recession and race and ethnicity were controlled to examine whether
minorities exhibited different utilization patterns under economic shock compared to
Whites.
In Chapter 3, data from the National Health Interview Survey (NHIS) from 2006-
2010 were used to identify adult cancer survivors and adults without a history of cancer.
Multivariate logistic regressions were applied to examine the prevalence of cost,
organizational and transportation barriers between survivors and the general population.
The likelihood of experiencing barriers was explored by race and ethnicity.
In Chapter 4, differences in the likelihood of experiencing access barriers among
survivors by race and ethnicity was explored. Data were merged from the 2000-2011
(NHIS) to identify adult cancer survivors who reported cost, organizational and
transportation barriers. Logistic regressions were applied to determine the likelihood of
reporting each type of barrier, while controlling for demographic and socioeconomic
variables. The Fairlie decomposition technique was applied to identify contributing
factors that explained differences in accessing care based by race and ethnicity.
Overall, results of the investigations demonstrate that: (1) breast and cervical
screening rates declined most among White women during the recession period, while
rates increased among Hispanic women during the same period; (2) minority cancer
survivors were significantly more likely to experience access-to-care barriers than
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Healthy People 2020 screening objectives and reduce racial and ethnic disparities in
accessing timely cancer care.
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As of January 2012, there were approximately 13.7 million cancer survivors in the
United States. The number is expected to increase to by 24% (18 million) within the next
ten years.1 A number of factors are contributing to the expected growth. An aging
population is increasing the number of persons at risk and advancements in surgical,
clinical and pharmacological therapies are improving survival rates.2 Education and
awareness initiatives, coupled with policies and practices that promote early detection
have also been efficacious.2 Collectively, these efforts are allowing persons with a history
of cancer to live longer and healthier lives.
While many survivors have benefited from such progress, minorities continue to
be disproportionately impacted. For example, for all cancer sites combined, the incidence
rate is 6% lower for African American women compared to White women; however, the
mortality rate is 16% higher in African American women.1 Incidence and mortality rates
are 15% and 33% higher, respectively, in African American men compared to White
men.1 Compared with Whites, the 5-year relative survival rate is lower in African
Americans for nearly every cancer site.1
These disparities are magnified when analyzed by certain cancer types. For
example, White women are more like to develop breast cancer; however, African
American women are more likely to die from breast cancer, even when the stage of
diagnosis is controlled.3–5 The mortality rate is 50% higher for African Americans
diagnosed with colorectal cancer compared with Whites; and mortality rates in cancers
associated with infectious agents (e.g. lung, liver, bile, gallbladder) are up to twice those
of non-Hispanic Whites.6,7
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The factors that contribute to racial and ethnic disparities in health outcomes and
medical treatment are multifactorial and they have been key topics in a number of
national reports. For example, the Institute of Medicine’s landmark reports, The Unequal
Burden of Cancer (1999) captured the unequal burden of cancer in communities of color
and Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare
(2002), highlighted the complex, deeply-rooted individual and system-level factors that
contribute to poor health outcomes in minority populations.8,9 Both reports assert that
disparities are driven by a complex set of social, economic, cultural, and health system
factors and findings have subsequently influenced policy, practice and research focused
on closing the gap in racial and ethnic health disparities.
While there has been progress in closing racial and ethnic gaps in health, when
compared to Whites, minorities with some of the most common forms of cancer continue
to be plagued with higher rates of disability and premature death.10–13 Due to unique
medical and social needs of the cancer survivor, receipt of timely access-to-care is critical
for promoting quality of life and longevity.9,14,15 Using the cancer care continuum as a
framework, this research investigates racial and ethnic differences in timely receipt of
cancer screening and treatment services.2,9,15
The Cancer Care Continuum
Figure 1.1 displays the cancer care continuum. Timely receipt of care at each
stage affects quality of life and overall life expectancy. Early screening promotes early
detection, resulting in treatment or intervention prior to advanced disease
progression.9,11,14,16 Due to the effects of cancer treatment, in addition to the need for
surveillance for recurrence, survivors need access to a comprehensive network of post-
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treatment services.9 Delaying or forgoing care at any stage of the survivorship continuum
can lead to undetected recurrence, mismanagement of side effects from treatment, and
mental health issues such as social isolation or poor mental health.15–18
Figure 1.1 The Cancer Care Continuum
The first study explores the first stage of the continuum (screening) by examining
differences in breast and cervical screening rates by race and ethnicity before and during
the Great Recession. The second and third studies focus on diagnosis, treatment, and post
treatment by exploring timely access to care among cancer survivors. According to the
National Coalition for Cancer Survivorship, an individual is considered a cancer survivor
from the time of diagnosis throughout the balance of his or her lifetime.15 Due to the
nature of the disease and its physical and mental impact on the body over the course of a
lifetime, cancer survivors are commonly documented in health services literature as a
vulnerable population.1,3,11 Unique medical needs include routine surveillance for primary
or secondary malignancies, monitoring chronic effects, and treatment for co-
morbidities.14 Survivors are also more likely to experience sexual dysfunction, infertility,
cosmetic changes, and impaired cognition. Compared to the general population, cancer
survivors are more likely to report lower perceived health status, psychological distress,
poorer mental health, greater role impairment due to emotional problems, and poorer
social well-being.14,19–22 Increased likelihood of these conditions warrant a greater level
of engagement with healthcare providers and the healthcare system.
Adapted from the Institute of Medicine9
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Figure 1.2 Five Dimensions of Access25
Conceptual Framework
The Andersen Model of Behavioral Health Services Use guided the selection of
independent variables for all outcome measures. The model assumes that a complex set
of conditions determine 1) whether or not individuals use health services; and 2) the
volume or frequency in which those services are consumed.23,24 Recognized as a
conceptual model that identifies factors that facilitate utilization of health services, the
Andersen Model focuses on three factors: predisposing, enabling factors, and need.
Predisposing factors include demographic, social characteristics or individual beliefs
about health services. Gender, age, marital status, education, income, US region,
language and nativity are selected as predisposing factors. Enabling factors include
access to prerequisite resources and the availability of health services in the local
community. Insurance and usual source of care are incorporated as enabling factors. Need
refers to an individual’s perceived severity of illness and subsequently, the need for
accessing health services. Perceived health status and comorbidities are included as need
factors.
Five Dimensions of Access
Figure 1.2 displays Penchansky and
Thomas’s Five Dimensions of Access.
Described as the concept of “fit” between
the patient’s needs and the system’s ability
to meet those needs, the Penchansky and
Thomas framework goes beyond the
traditional concepts of cost and
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availability.25 Due to the need for frequent medical visits and specialty care services,
access-to-care barriers are especially relevant for cancer survivors. Availability is defined
as the relationship between need and physical availability.25 Accessibility is defined as
the relationship between the location of supply and the location of clients, taking account
of client transportation resources, travel time, distance and cost.25 Accommodation refers
to the state in which supply services are organized and able to meet client specific
needs.25 Accommodation barriers have received national attention and initiatives are
underway to address those barriers. For example, the accommodation dimension is
aligned with “Superb Access to Care,” the first domain of the Institute of Medicine’s six
domains of quality.26 Established to promote patient centered care and the establishment
of a medical home, or usual source of care, the Institute of Medicine describes the
following as “superb access to care:” ease of making an appointment, ability of patients
to select the day and time of their appointment, short wait times, and office hours that
make primary care readily accessible on nights, weekends, and holidays. Affordability is
expressed as the relationship of prices of services and providers’ insurance or deposit
requirements to the clients’ income, ability to pay, and existing health insurance.25 While
medical providers may be geographically available, acceptable, and accommodating,
consistent utilization is contingent upon the consumer’s ability to afford the services
offered. Acceptability is defined as the relationship of clients’ service expectations
compared to what is actually delivered.25
As part of this research, three outcome variables that are linked to four
dimensions are examined: Affordability is captured by forgoing or delaying care due to
costs. Accommodation is captured by delaying care due to organizational barriers (i.e.,
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cannot get through on phone, wait too long, could not get an appointment soon enough,
office not open). Delaying care due to transportation is examined to determined
accessibility and availability barriers. Due to survey limitations, barriers associated with
acceptability were not explored.
Chapters 2, 3 and 4
In Chapter 2, Analyses of Racial and Ethnic Differences in Breast and Cervical
Cancer Screening before and during the Great Recession, a national sample is used to
conduct the first study that examines breast and cervical cancer screening rates by race
and ethnicity before and during the Great Recession of 2007-2009. Chapter 3, Healthcare
Access Barriers among Cancer Survivors by Race and Ethnicity, contributes to the
literature by examining the prevalence of cost, organizational, and transportation barriers
among cancer survivors, compared to the general population. The analysis is augmented
by exploring each barrier within the context of the interaction of race/ethnicity and cancer
history. In Chapter 4, Decomposing Differences in Medical Care Access among Cancer
Survivors by Race and Ethnicity, the magnitude of racial and ethnic barriers to care are
examined by conducting an 11-year analysis using adult cancer survivors as the
population of study. By applying the Fairlie decomposition method, factors that
contribute to the disparities are quantified.
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CHAPTER 2:
Analyses of Racial and Ethnic Differences in Breast and Cervical Cancer
Screening Before and During the Great Recession
INTRODUCTION
Economic recessions have historically had a negative impact on preventive
services and overall health services utilization.27 Most recently, millions of Americans
were affected by the Great Recession of 2007-2009. Unemployment, loss of employer-
sponsored health insurance, reduced net worth and other social factors that contribute to
economic vitality were compromised.28–30 In December 2007, the national unemployment
rate was five percent and by December 2009, the unemployment rate rose to more than
nine percent (9.5%).29 Consequently, 5.8 million Americans loss employer–based health
insurance coverage and the uninsured rate rose 2.7%, resulting in an additional 5.6
million uninsured Americans.31 Furthermore, the unemployment rate of the Great
Recession rose fastest, compared to the last six recessions in American history.29
There were also noteworthy differences in how the recession affected racial and
minority populations. As of December 2009, the unemployment rate for African
Americans was 16.2%, 12.8% for Hispanics and 9.0% for Whites.29 Although the
unemployment rate for Whites was the lowest, Whites make up the majority of the
population. The job loss resulted in 3 million newly uninsured Whites, 0.6 million newly
uninsured African American and 1.1 million newly uninsured Hispanics.31 Only a few
investigations have examined the impact of the Great Recession on health services
utilization and consistent with prior recessions in American history, the underlying theme
is a reduction in health services utilization among the general population.27,31–33
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Inarguably, early detection through screening can be lifesaving and due to the
proven benefits of early detection for breast and cervical cancer, national screening goals
have been determined and included as part of Healthy People 2020.34 Timely
mammography screening can reduce breast cancer mortality rates by 15-30%35–37 and if
detected early, cervical cancer is one of the most curable forms of cancers.38 However,
receipt of timely health services is contingent upon a number of financial and
nonfinancial factors, many of which connect to the state of the economy.27,30,31,39 Due to
the importance of early detection, analyses of the impact of the recession on national
cancer screening efforts and identification of populations and communities most
impacted are needed. Findings can help target those who have forgone or delayed
preventive screening services due to varying effects of the recession.
To the best of my knowledge, this is the first comparative analysis of breast and
cervical screening rates during the Great Recession. Given the loss of health insurance
and/or wealth reduction, I hypothesize that the likelihood of receiving breast and cervical
screening decreased significantly during the Great Recession, compared to a precession
period. Using age-specific guidelines established by the United States Preventive
Services Task Force,40 this study contributes to the literature by examining trends in
breast and cervical cancer screening rates before and during the recession periods.
Furthermore, analyses by race and ethnicity provide insight on how specific populations
were affected.
Conceptual Framework
There is clear evidence that health service utilization is based on system-level
factors, such as insurance status and access to and utilization of a usual source of
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care.11,41–43 Moreover, personal characteristics, such as race/ethnicity, educational
attainment, marital status and perceived health status are also well documented in the
literature as contributors to health service utilization.11,42,43 Therefore, Andersen’s
Behavioral Model of Health Services Use was selected as a guide for this study. The
model acknowledges predisposing, enabling, and need factors that influence or predict
utilization of healthcare services.23,24 Predisposing factors describe the natural tendency
of individuals to use health services and include demographic variables such as race,
ethnicity, age, gender, marital status, and occupation.23,24 Enabling factors refer to the
resources needed for the use of health services and include income, insurance coverage,
and geographic location. Need factors refer to health status or illness, which warrants
utilization of health services.15
METHODS
Data
Data from the consolidated Medical Expenditure Panel Survey (MEPS) were used
for the analyses.44 The MEPS is a longitudinal survey sponsored by the Agency for
Healthcare Quality and Research (AHQR). The survey provides information on the
utilization of health services by a nationally representative sample of civilian, non-
institutionalized persons in the United States. African Americans and Hispanics are
oversampled and demographic and socioeconomic indicators of respondents are also
provided.44,45
Using the United States Preventive Service Task Force (USPSTF) age-appropriate
screening recommendations,40 as well as Healthy People 2020 age-based screening
recommendations,34 the research focuses on breast and cervical screening among White,
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Hispanic and African American women. For breast screening, the sample includes those
between the ages of 50 and 74. Receipt of mammography within the past two years is the
dependent variable. For cervical screening, the sample includes women between the ages
of 21 and 65. Women who reported having a hysterectomy are excluded. Receipt of a Pap
smear within the past three years is the dependent variable. Screening frequencies
between the pre-recession period (2004 and 2005) and the recession period (2007 and
2009) are compared.
Key Independent Variables
A dummy variable is created as an indicator for the economic recession, i.e. it
equals to 1 if the survey years are 2009-2010, 0 if survey years are 2004-2005. The
interaction terms of race and ethnicity with the recession interaction are controlled to
explore if racial and ethnic groups have different utilization patterns during the recession
period.
Other Independent Variables
Following the Andersen model, predisposing, enabling and need factors are
controlled. Predisposing factors include: marital status (married - reference), education
(no high school degree - reference), primary language (English – reference), US Region
(Northeast – reference) and nativity (US born – reference). Enabling factors include
insurance (uninsured – reference), income (>200 Federal Poverty Level – reference),
employment status (employed - reference), usual source of care (no – reference) and
urban/non-urban (nonurban – reference). Need factors include perceived health status
(excellent – reference) and comorbidities (no comorbidity– reference). Comorbidities
include common noncancerous conditions that typically require medical attention within
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a 12-month period: coronary artery disease, diabetes, hypertension, high cholesterol,
osteoarthritis, depression, and anxiety. A binary variable that equaled 1 is constructed if
respondents have any of the conditions and 0 otherwise.
Analysis
Rates of receiving a mammograms and Pap smears for each race and ethnicity
before and during the Great Recession are presented. Sample characteristics are
summarized according to eligibility for mammogram and/or Pap smear. Multivariate
logistic regressions are applied to estimate the likelihood of timely receipt of screening
services based on USPSTF recommendations. The interaction of the recession and
likelihood of screening by race and ethnicity is also analyzed. Stata 12.0 (Stata
Corporation, College Station, Texas) is used for all analyses. Appropriate survey
commands are used for all analyses to account for sample weighting and the complex
survey design to ensure correct variance estimation.
RESULTS
Breast Cancer Screening
Table 2.1 provides characteristics of the population of women between the ages of
50 and 74 who were eligible for mammogram: White 6936 (64%), African American
2074 (19%), and Hispanic 5333 (17%). On average, White women were more likely to
report excellent health (18%) compared to Hispanic (8%) and African American women
(8%), and less likely to have a comorbidity (71% among Whites, 73% among Hispanics,
and 79% among African Americans). White women were more likely to have private
insurance (74%), compared to Hispanics (40%) and African Americans (51%).
Approximately half of all races and ethnicity were employed and the majority had a
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usual source of care - White 92%, Hispanic 84% and African American (90%). Fifty-
four percent (54%) of Hispanics did not speak Spanish as a primary language and 67%
of Hispanics were not born in the United States.
Figure 2.1 provides summary statistics of mammography rates before and during
the recession periods. There was a slight decrease in the percentage of White women
screened (78% before and 76% during the recession). Percentages of African American
women who were screened were unchanged at 76% and screening among Hispanic
women rose 6 percentage points (71% to 77%).
Table 2.2 displays multivariate results, controlling for the recession indicator,
race/ethnicity and other covariates. Overall, compared to the pre-recession period,
women were significantly less likely to receive a mammogram during the recession
Based on age-appropriate recommendations established by the United States Preventive Services
Task Force: Women ages 50-74
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period (OR .82 p<0.001). African American women were more likely to have a
mammogram compared to White women (OR 1.31 p<.01). The interaction term between
Hispanics and the economic recession was significant (OR 1.39, p=.05), which indicates
that mammography screening among Whites was lower than Hispanics during the
recession period. Furthermore, findings show an increase in screening among Latinas
during the recession period, compared to the prerecession period. The interaction term
between African American women was not significant, which indicated that screening
patterns were unchanged among African American women during the recession,
compared to White women.
In addition, multivariate regression results show that married women were more
likely to have a mammogram than unmarried women (OR 1.36 p<.001). The likelihood
of receiving a timely mammogram was significantly lower for women who did not speak
English as a primary language compared to those who did (OR .55 p<0.001). Women
without a high school degree (reference) were less likely to be screened than those with
degrees. Need factors are examined by perceived health and comorbidities. In general,
women with higher perceptions of health status were more likely to be screened than
those with lower perceptions of their health status and those with comorbidities were
more likely to be screening than those without comorbidities (OR 1.74 p<0.001).
The likelihood of screening was greatest among those with incomes more than
200 percent of the federal poverty level (reference). Access to private insurance, public
insurance, and a usual source of care were the most significant enabling factors.
Compared to uninsured women (reference), those with private insurance were almost
three times more likely to be screened (OR 2.97 p<0.001) and those with public
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insurance were 2.5 times more likely to be screened (OR 2.50 p<0.001). Residents of
the Northeast Region (reference) of the country were most likely to be screened than
those in other regions. The Midwest and South fared worse (OR .73 p<0.001; OR .73
p<0.001, respectively).
Cervical Cancer Screening
There were 19,957 women between the ages of 21 and 65: White 10,845 (54%),
Hispanic 5333 (27%) and African American 3779 (19%) (Table 2.1). The majority of
White women perceived their health as very good or excellent (61%), compared to 44%
of Latinas and 46% of African American women. Forty-five percent (45%) of African
American women reported a comorbid condition, compared to 44% of Whites and 36%
of Hispanics. Hispanics were least likely to have private insurance (41%), compared to
54% of African Americans and 77% of Whites. The majority of all populations were
employed (White – 78%, Hispanic – 65% and African American – 74%) and Hispanics
were less likely to have a usual source of care (31%). Fifty-three percent (53%) of
Hispanics did not speak English as a primary language and 63% of Hispanics were not
born in the United States.
Figure 2.2 provides summary statistics of Pap Smear rates before and during the
recession periods. There was a slight decrease in the percentage of White women
screened (88% before and 85% during the recession). Percentages of African American
women who were screened were unchanged at 89% and screening among Hispanic
women rose three percentage points (84% to 87%).
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According to the multivariate regressions (Table 2.2), overall, compared to the
prerecession period, women were less likely to obtain a Pap smear during the recession
period (OR .79 p<.001). However, African American women were more likely to have a
Pap smear than White women (OR 1.78 p<.001). Compared to the prerecession period,
Hispanic women were more likely to be screened during the recession period (OR 1.56
p<.001). The percentage of White women with a timely Pap Smear dropped three
percentage points during the recession; 88% before; 85% during (Figure 2.2). However,
percentage rates for Hispanics increased from 84% prior to the recession to 87% during
the recession. Rates for African Americans remained unchanged at 89%.
According to multivariate regressions for the two time periods (Table 2.2),
married women were more likely to be screened than women who were not married (OR
1.75 p<.001). Those with a college degree were most likely to be screened (OR 2.08
p<.001), followed by those with an advanced degree (OR 1.64 p<.001) compared to those
without a degree (reference). Consistent with trends in breast screening, women with
Based on age-appropriate recommendations established by the United States Preventive Services
Task Force: Women ages 21-65
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higher perceptions of health status were more likely to be screened than women with
lower perceptions of health status (p<.05). However, screening rates were higher for
those with comorbidities (OR 1.33 p<.001) compared to those with comorbidities.
Access to insurance, employment, and a usual source of care were the most
significant enabling factors. Compared to uninsured women (reference), those with
private insurance and public insurance were more than two times more likely to be
screened (OR 2.17 p<.001; OR 2.15 p<001). Unemployed women were less likely to be
screened than employed women (OR .72 p<.001) and women with a usual source of care
were more than two times more likely to be screened than those without a usual source of
care (OR 2.08 p<.001). Although there were no statistically significant findings by
region, women in urban areas were more likely to be screened than women in non-urban
areas (OR 1.20 p<.05).
During the recession period, women were less likely to obtain a Pap smear
compared to the prerecession period (OR .79 p<.001). Compared to White women
(reference), African American women were more likely to receive a pap smear (OR 1.78
p<.001). Hispanic women were more likely to receive a timely Pap smear during the
recession period, compared to the prerecession period (OR 1.56 p<.001).
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Table 2.1 Demographic Characteristics of Sample Based on USPSTF
Age-Appropriate Recommendations






N=6936(%) N=1884(%) N=2074(%) N=10845(%) N=5333(%) N=3779(%)
Age (years) 60 59 59 41 38 39
Marital Status
Married 4230(61) 998(53) 728(32) 6398(59) 2880(54) 1020(27)
Not Married 2706(39) 886(47) 1346(68) 4447(41) 2453(46) 2759(73)
Perceived Health
Excellent 1248(18) 151(08) 167(8) 2711(25) 907(17) 680(18)
Very Good 2289(33) 375(21) 477(23) 3904(36) 1440(27) 1058(28)
Good 2081(30) 659(35) 746(36) 3037(28) 1973(37) 1285(34)
Fair 902(13) 527(28) 498(24) 868(08) 853(16) 605(16)
Poor 416(06) 151(08) 186(9) 325(03) 160(03) 151(04)
Comorbidity
Yes 4924(71) 1375(73) 1638(79) 4772(44) 1920(36) 1700(45)
No 2012(29) 509(27) 436(21) 6073(56) 3413(64) 2073(55)
Education
No degree 1040(15) 1168(62) 663(32) 1193(11) 2560(48) 831(22)
High school
degree 3606(52) 471(25) 954(46) 4989(46) 1919(36) 2003(53)
College degree 1040(15) 113(06) 166(08) 2386(22) 427(08) 454(12)
Advanced degree 1317(18) 131(07) 290(14) 2277(21) 427(08) 491(13)
Income
> 200% FPL 693(10) 414(22) 539(26) 1410(13) 1547(29) 1171(31)
< 100% FPL 1040(15) 527(28) 539(26) 1735(16) 1653(31) 983(26)
100-200% FPL 5202(75) 942(50) 996(48) 7700(71) 2133(40) 1625(43)
Insurance
Uninsured 486(07) 452(24) 249(12) 1193(11) 1866(35) 605(16)
Private 5132(74) 754(40) 1058(51) 8351(77) 2186(41) 2040(54)
Public 1317(19) 678(36) 767(37) 1301(12) 1281(24) 1134(30)
Usual Source of
Care
Yes 6381(92) 1583(84) 1867(90) 9001(83) 3680(69) 2948(78)
No 555(8) 301(16) 207(10) 1844(17) 1653(31) 831(22)
Employment
No 3121(45) 1037(55) 1058(51) 2386(22) 1866(35) 983(26)
Yes 3815(55) 847(45) 1016(49) 8459(78) 3467(65) 2796(74)
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Notes: Source : Medical Expenditure Panel Survey 2004/2005 and 2009/2010
Table 2.2: Interaction of Recession and Screening by Race and Ethnicity and
Results of Multivariate Analyses after Controlling for the Recession
Pap
Smear Mammogram
OR p-value OR p-value
Key Independent Variables
Before recession (year =2004, 2005) ref ref
Recession indicator (year =2009, 2010) 0.79 0.00 0.82 0.00
White ref ref
African American 1.78 0.00 1.31 0.01
Hispanic 1.11 0.35 0.94 0.68
Interaction: African American & Recession 1.12 0.41 1.10 0.50
Interaction: Hispanic & Recession 1.56 0.00 1.39 0.05
Other Covariates
Age 0.98 0.00 1.00 0.69
Marital Status
Not Married Ref ref




English 6936(100) 867(46) 2074(100) 10845(100) 2506(47) 3779(100)
Other - 1017(54) - - 2827(53) -
Urban/Non-
urban
Urban 5271(76) 1714(91) 1784(86) 8676(80) 4853(91) 3288(87)
Non-urban 1665(24) 170(9) 290(14) 2169(20) 480(9) 491(13)
US Region
Northeast 1249(18) 301(16) 332(16) 1952(18) 693(13) 642(17)
Midwest 1803(26) 94(5) 332(16) 3037(28) 427(8) 681(18)
South 2497(36) 717(38) 1224(59) 3579(33) 1813(34) 2154(57)
West 1387(20) 772(41) 186(09) 2277(21) 2400(45) 302(8)
Nativity
US born 6752(96) 622(33) 1950(94) 10411(96) 1973(37) 3477(92)
Non US born 184(4) 1262(67) 124(6) 434(4) 3360(63) 302(8)
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Excellent ref ref
Very good 0.85 0.04 0.90 0.29
Good 0.73 0.00 0.71 0.00
Fair 0.63 0.00 0.59 0.00
Poor 0.43 0.00 0.46 0.00
Comorbidity
No ref ref
Yes 1.33 0.00 1.74 0.00
Education
No degree ref ref
High school degree 1.12 0.11 1.36 0.00
College degree 2.08 0.00 1.78 0.00
Advanced degree 1.64 0.00 1.73 0.00
Income
>200% FPL ref ref
<100% FPL 1.06 0.54 0.73 0.00
100- 200% FPL 1.01 0.92 0.72 0.00
Insurance
Uninsured ref ref
Private 2.17 0.00 2.97 0.00
Public 2.15 0.00 2.50 0.00
Usual Source of Care
No ref ref
Yes 2.08 0.00 2.58 0.00
Employment
Employed ref ref
Unemployed 0.72 0.00 0.92 0.25
Primary Language
English ref ref
Other 0.82 0.09 0.55 0.00
Urban/Non-urban
Non-urban ref ref
Urban 1.20 0.01 1.03 0.72
US Region
Northeast ref ref
Midwest 0.94 0.47 0.73 0.00
South 0.99 0.86 0.73 0.00
West 1.04 0.68 0.78 0.01
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Nativity
US born ref ref 0.68
Non US born 0.94 0.59 1.05 0.68
Notes: Source: Medical Expenditure Panel Survey 2004/2005 and 2009/2010
Women 50-74(n=10,894); Women 21-65(n=19,957)
DISCUSSION
This study contributes to the literature by examining racial and ethnic trends in
breast and cervical cancer screening rates before and during the Great Recession.
Findings also provide insight into how the recession period may have impacted Healthy
People 2020 breast and cervical cancer screening goals. Furthermore, comparative
findings provide insight on specific populations and geographic locations that should be
targeted for local and national screening efforts. Social and demographic factors
associated with screening were incorporated in the analyses to capture the magnitude of
predisposing, enabling and need factors that are associated with health services
utilization.
Consistent with findings from prior studies on the impact of preventive health
services utilization during recession periods,27,33,39 screening rates for breast and cervical
cancer screenings dropped during the Great Recession. Since it is estimated that three
million Whites loss insurance coverage during the recession,31 it is not surprising that
White women contributed most to reduction. The decline has resulted in a negative
impact on the Healthy People 2020 objective, which identifies 81% as the national target
for breast screening and 93% as the national target for cervical screening.34 Due to the
likelihood of advanced-stage diagnosis, the implications can be serious and costly.4,5,46,47
Efforts are needed to re-engage this population in education and screening services to
reduce risks and promote early detection.
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Screening rates among Hispanics were higher during the recession period than
before the recession period. A six-percent percentage increase for breast screening and a
three-percent increase in cervical screening during the recession period, compared to the
pre-recession period, is moving Latinas closer to national targets. This is especially
noteworthy since Latinas have been historically diagnosed with the both cancers at more
advanced stages than Whites.48,49 Screening efforts funded by the National Breast and
Cervical Cancer Early Detection Programs have made a significant contribution to the
overall numbers of women screened. Latinas, in particular have benefitted -
approximately 312,000 Latinas were screened for cervical cancer and 267,000 were
screened for breast cancer during 2006 through 2011.50 In addition, philanthropies, such
as the Avon Foundation and the Susan B. Komen Foundation have made significant
contributions in heightening awareness and expanding access to breast screening –
particularly among communities of color.51,52 Improved screening among Latinas may
also be the result of local and national partnerships that offer evidence-based, culturally-
tailored outreach and preventive services, specifically among safety-net provider
groups.53
Consistent with prior research findings, insurance and usual source of care were
the strongest predictors of screening.42,54,55 It should also be noted that the gap in
likelihood of screening between those with private insurance and public insurance is
fairly small, suggesting that public and private providers are achieving a fairly consistent
level of performance. Based on socio-economic data, African American screening rates
may have remained unchanged between the two periods for two possible reasons: 1)
although African Americans were adversely impacted by the recession, their income
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reductions were not as dramatic as Whites31 and 2) compared to Whites, higher
proportions of African Americans have lower incomes; those populations may have
already been covered by Medicaid or other forms of public insurance.31,56
In 2002, Fiscella and colleagues found that poor English fluency is a contributor
to healthcare access disparities by ethnicity, even when controlling for insurance.57
Results of this study corroborate those findings, since there was a significant association
between primary language and likelihood of timely screening. Screening among women
50 and older who did not speak English as a primary language was significantly lower
than those who spoke English as a primary language. Therefore, culturally and
linguistically tailored outreach services for these populations may be helpful. In addition,
subsequent research that explores social or cultural dynamics that may impact decision
making for these populations is needed.
Consistent with US regions most impacted by unemployment and uninsurance
during the recession, breast screening in the Midwest and South was lowest, followed by
the West.30,31 The region with the largest percentage increase in the number of newly
uninsured persons was the Midwest and increased in uninsured populations were highest
in the South and West.31 The Northeast region fared better, mainly because of more
widespread public insurance programs with high eligibility thresholds.31 Since women in
urban communities were more likely to be screened for cervical cancer, special efforts are
needed to screen residents of rural communities in the South, Midwest and West who
have elected to forgo screening due to factors associated with the recession.
There are many provisions of the Patient Protection and Affordable Care that will
have a positive impact on screening rates; however, expanded Medicaid coverage, health
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insurance exchanges, and no cost sharing requirements for breast and cervical screening
are expected to make a favorable impact.58 As the provisions are phased in through 2019,
there are opportunities to educate those who are most likely to benefit. Widespread local
and national efforts are needed to ensure that those who have been affected by the
recession understand the law and how can benefit them.
Limitations: This study had several limitations. First, the analyses were cross-
sectional and do not explore causality between events that occurred during the recession
period and decreased screening rates. Second, the MEPS questionnaire relies on patient
recall and thus survey answers may have recall bias. Third, although I controlled for the
demographic and socioeconomic status of the respondents, variables, such as physician-
patient relationship or cultural preference, were omitted due to the data limitation. These
omitted variables may directly or indirectly influence the rates of receiving cancer
screening tests. Fourth, although I controlled the geographic measures such as
metropolitan statistical area (MSA) status and US Census regions, future research should
focus on the state variation during the economic recession. Due to five and ten year
recommendations for sigmoidoscopy and colonoscopy, respectively, data are not
currently available to assess the impact of the recession on colorectal screening. Future
research is needed as data become available.
CONCLUSION
The findings in this study corroborate an abundance of literature that underscores
the important role of insurance and usual source of care in accessing preventive screening
services. Since screenings for women with public insurance remained relatively high and
unchanged during the recession, the case for expanding insurance coverage and a usual
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source of care is further strengthened. While the provisions of the ACA will support these
opportunities, collaborative efforts between health services providers, local and federal
government, not-for-profit stakeholders and private industry are needed. These
partnerships can help ensure that those most impacted by the recession are able to re-
enter the system of care and receive timely and appropriate preventive health services.
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CHAPTER 3:
Healthcare Access Barriers among Cancer Survivors by Race and Ethnicity
INTRODUCTION
Cancer is one of the most prevalent chronic diseases affecting millions of
Americans. According to the National Coalition for Cancer Survivorship (NCCS), a
cancer survivor is anyone who has received a cancer diagnosis at some during his or her
lifetime, including those who are in remission or cancer free.15 In 2002, there were
approximately nine million cancer survivors and the number of survivors increased
substantially to 13.7 million in 2012, more than 150% of the prevalence rate 10 years
ago.1,14 The increase in cancer survivorship is attributable to an aging population, as well
as national efforts to promote early detection. Advancements in technology, clinical
treatment and pharmacological therapies are also helping survivors live longer and
healthier lives.1,2
Despite these accomplishments, survivors still require access to a spectrum of
medical and support services throughout the duration of their lives. Timely access to
services that address the mental and physical effects of treatment can be lifesaving.17,59
Unique medical needs include routine surveillance for primary or secondary
malignancies, monitoring for chronic effects, and treatment for co-morbidities, such as
depression.17 Survivors are also more likely to experience sexual dysfunction, infertility,
cosmetic changes, and impaired cognition.17 Compared with persons with no history of
cancer, cancer survivors are more likely to be in fair or poor health and have functional
limitations.14 These findings corroborate the importance of access and utilization of
primary care and support services.17
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Racial and ethnic disparities in treatment and access to care among cancer
survivors are well-documented in health services research.1,8,10,11,59,60 For example, a
number of researchers have found that approximately 30-50% of minority women do not
receive timely follow-up care after an abnormal breast screening.4,5,46,61 Ward and
colleagues (2004) found that Whites were more likely than other racial/ethnic groups to
receive timely and aggressive treatment for colorectal cancer.10 These differences in
access to care contribute to poor health status and disparities in mortality by race and
ethnicity.11
System-level factors such as transportation, organizational characteristics and
costs are also documented in the health services literature as predictors of medical
treatment and support service utilization.62–64 Guidry and colleagues (1998) found that
African American survivors were more likely than Hispanic and White survivors to: 1)
report they lost medical coverage after diagnosis, 2) be denied medical coverage after
diagnosis, 3) be denied coverage after changing jobs, and 4) reach their insurance
spending limits.62 The researchers also found African American and Hispanic survivors
more likely to report transportation difficulties than Whites.65
There are also organizational characteristics that result in delaying or forgoing
medical care. Examples include limited hours of operation, long wait times, inability to
get through on the phone, and inability to obtain a timely appointment.66–68 Kullgren and
colleagues (2011) found that 17.5 percent of U.S. adults delayed care due to
organizational barriers.69 However, there is limited research on the impact of
organizational characteristics on delaying or forgoing medical care, specifically as it
relates to cancer survivors and racial and ethnic populations.62
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A number of studies have examined access-to-care barriers related to cost.23,66,68
For example, Weaver and colleagues (2010) found that cancer survivors were more
likely to delay care due to cost when compared to the general population.64 Sabatino and
colleagues (2006) found that uninsured survivors and survivors on public insurance were
more likely to delay care due to cost.63 This study contributes to the body of literature by
going beyond costs and examining the impact of organizational and transportation
barriers among cancer survivors, using the general population as a comparison group.
This deeper analysis of the interaction of cancer survivorship by race and ethnicity and
the frequency of barriers provides additional insight into the relationship between
race/ethnicity, access-to-care and survivorship.
Conceptual Framework
Access to health services is a critical component of disease prevention and disease
management. While affordability and geographic access to health services are most
commonly identified in the literature as barriers to care, there are organizational barriers
that impede access and utilization of timely care.66–68 Awareness of and attention to
those dynamics is especially noteworthy in developing and designing health services to
meet the needs of cancer survivors.
This study examines barriers to medical care among cancer survivors by using
Penchansky and Thomas’s Dimensions of Access as a conceptual framework.25
According to the framework, access is a concept that represents the degree of “fit”
between the client and the healthcare system. Affordability is based on the relationship
of prices or fees and the clients’ perception of value. Accommodation addresses the
state in which supply services are organized and able to meet client specific needs.
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Accessibility captures the relationship between location of supply and location of
clients.25
The purpose of this study is to examine the prevalence of three common access-
to-care barriers and determine whether cancer history and race/ethnicity are associated
with the likelihood of reporting barriers. Analyses include an examination of similarities
and differences between cancer survivors and the general population and the reasons for
forgoing medical care based on costs (Affordability), transportation (Accessibility), and
organizational characteristics (Accommodation). Moreover, each barrier is explored
within the context of the interaction of race/ethnicity and cancer history.
METHODS
Data from the 2006-2010 National Health Interview Survey (NHIS) are merged
and analyzed to achieve a sufficient sample size. The NHIS is based on approximately
35,500 households or 87,500 persons in the noninstitutionalized civilian population.70
The survey is designed to track the incidence and prevalence of illness, accidental
injuries, the prevalence of chronic conditions and impairments, the extent of disability,
and the utilization of healthcare services. The NHIS survey design includes clustering,
stratification, and multistage sampling. A different sample population is identified each
year, and African Americans and Hispanics are over sampled.70
Cancer survivors are defined as persons age 18-64 who report “ever having” any
of the five most common forms of cancer in the United States: breast, cervical, colon,
prostate, and melanoma (n=2,281). Adults without cancer are defined as persons age 18-
64 who report not having any form of the five forms of cancer, nor any other form of
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cancer (n=243,925). Forgoing or delaying medical care within the past 12 months is the
dependent variable.
Independent variables included sex, race/ethnicity, primary language, age,
insurance, income, marital status, level of education, perceived health status, co-
morbidities, usual source of care and geographic region. Insurance coverage is
categorized as: no insurance, private insurance, and public insurance (Medicaid, state
insurance health programs, military plans, or Medicare). Co-morbidities include eleven
noncancerous conditions that typically require medical attention within the past 12
months: coronary artery disease, stroke, liver conditions, diabetes, heart conditions,
hypertension, weak or failing kidneys, arthritis, ulcer, asthma, and bronchitis. Persons
with one or more of these conditions are compared to those with no co-morbidities.
Barriers to Care
Barriers to care are classified into three broad categories: cost, organizational, and
transportation. Responses for all questions are dichotomous. The following variables are
collapsed into the cost category: delayed medical care due to cost, needed but could not
afford medical care, needed but could not afford prescription(s), and needed but could
not afford mental health. Organizational barriers are based on delivery system
limitations. Due to low response rates, I collapse four variables into one category: could
not get an appointment, office not open, could not get through on phone, and long wait
in doctor’s office. Only one question in the survey addresses transportation – “delayed
care due to transportation.”
Data Analysis
Stata 11.0 (Stata Corporation, College Station, Texas) is used for all analyses.
The NHIS is based on a number of sampling strategies, including oversampling of
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racial/ethnic populations, stratification, and clustering. Thus, Stata 11.0 survey
commands are used for the analyses to account for sample weighting and the complex
survey design to ensure correct variance estimation.
RESULTS
Cancer Survivors. There were 2,281 adults age 18-64 with a history of one or
more of the five forms of cancer: breast (n=790), cervical (n=679), colon (n=201),
prostate (n=256) and melanoma (n=355). Approximately 77% (n=1772) were women
and 23% (n=509) were men (Table 3.1; 3.4). Nearly 81% were White, 9.2% African
American, 5.7% Hispanic and 4.2% other races. The majority of respondents reported a
usual source of care and spoke English as a primary language (91% and 99%,
respectively). Seventy-five percent of persons with a history of cancer were ages 45-64.
Approximately 67% reported educational levels less than a bachelor’s degree; 67% had
private insurance. The majority of cancer survivors (62.9%) reported at least one or more
of the 11 co-morbidities (Table 3.1).
General Population. There were 243,925 persons with no history of cancer in the
sample; 49.7% were male and 50.3% female. Sixty-six percent were White, 12.3%
African American, 15.1% Hispanic and 6.7% other races. The majority of respondents
(67.6%) reported no usual source of care and 95.7% spoke English as a primary
language. Nearly 71% reported educational levels less than a bachelor’s degree; 67.2%
had a private insurance. Only 14.7% reported one or more of the 11 co-morbidities
(Table 3.1).
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Table 3.1: Demographic Characteristics of Adults With and Without a History of Cancer
Characteristics
Cancer Survivors (n=2,281)*
n WT% (95% CI)
Adults without Cancer (n=243,925)



























































































































































































































WT% indicates weighted percentage; 95% Confidence Interval
*Breast, cervical, prostate, colon cancer, melanoma
Access to Care Barriers among Survivors, the General Population and Racial/Ethnic
Minorities
Overall, 31% of cancer survivors reported at least one of the three barriers
compared to 15% of the general population (P<.05). Eighteen percent (18%) of survivors
reported cost as a barrier, compared to 11% of the general population; 14% of survivors
reported organizational barriers compared to 4% of the general population, and 3%
reported transportation barriers, compared to <1% of the general population (p<.05).
As presented in Table 3.2, cost was more likely to be considered as a barrier by
African American and Hispanic survivors (24.6%, 24.3%, respectively) compared to
Whites and other race survivors. However, the frequency of cost as a barrier in the
general population was fairly consistent among Whites (11.8%), African Americans
(11.6%), and Hispanics (11.9%). Twenty-one percent (21%) of African American cancer
survivors reported organizational barriers compared to 16.3% of other races, 14.3% of
Hispanics and 13.9% of Whites. More Hispanic cancer survivors reported transportation
barriers (7.9%) compared to other races (4.7%), African Americans (4.1%), and Whites
(3.1%) (Table 3.2).
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n WT% (95% CI)
Adults without Cancer





















































































WT% indicates weigthed percentage; 95% Confidence Interval
*Couldn't get appointment soon enough, waited too long to see the doctor, clinic/doctor's office wasn't open, couldn't
get through on the phone
Logistic regression results are presented in Table 3.3. In the unadjusted model,
adults with a history of cancer were more likely to report cost as a barrier (OR 1.76
p<.001). The interaction between cancer survivors and African Americans and Hispanics
who reported costs as barriers was statistically significant in the adjusted model (OR
1.55 p<.05; OR 2.30 p<.05, respectively).
Compared to the general population, adults with a history of cancer were more
likely to report organizational barriers in unadjusted and adjusted models (OR 3.81 CI
3.35-4.34; OR 1.19, 1.01-1.39) (Table 2.3). Hispanics and persons from other races were
more likely than Whites and African Americans to report organizational barriers in the
adjusted model (OR 1.20 p<.01; 1.07 p<.05). In unadjusted models, African American
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cancer survivors were more likely than White survivors to report organizational barriers
(OR 1.70 p<.05). However, in adjusted models there were no significant interactions
between race and cancer survivors in relation to organizational barriers.
Adults with a history of cancer were almost five times more likely to report
transportation as a barrier, compared to the general population (OR 4.75 p<.001) in
unadjusted models. However, this association became non-significant in adjusted models.
There were also noteworthy disparities in transportation barriers by race/ethnicity
regardless of cancer survivorship. In the adjusted model, African Americans and other
races in the general population were more likely to report transportation barriers than
Whites (OR 1.36 p<.001; 1.64 p<.001). Hispanics were more likely to report
transportation barriers in the unadjusted model only (OR 2.60 p<.001). There were no
statistically significant findings in the interaction between cancer survivors and
race/ethnicity in relation to transportation barriers (Table 3.3).
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Table 3.3 Barriers to Medical Care among Adults by Race/Ethnicity and Cancer Survivorship
Unadjusted Model Adjusted Model†
OR 95% CI p-value OR 95% CI p-value
Race/Ethnicity
White 1.00 1.00
African American 0.96 0.92-1.02 .21 0.66 0.62-0.70 <.001
Hispanic 1.00 0.96-1.05 .93 0.63 0.59-0.68 <.001
Other .68 0.63-0.73 <.001 0.59 0.54-0.65 <.001
Cancer History
No 1.00 1.00




African American 1.55 1.00-2.42 .05 1.55 1.05-2.28 .03
Hispanic 1.48 1.09-2.01 .01 2.23 1.28-4.15 .01




African American 0.96 0.88-.099 .03 0.91 0.84-0.99 .04
Hispanic 1.13 1.06-1.21 .001 1.20 1.10-1.32 <.001
Other 1.02 0.94-1.11 .62 1.18 1.07-1.30 .001
Cancer History
No 1.00 1.00




African American 1.70 1.12-2.57 .01 1.00 0.63-1.58 .99
Hispanic 0.89 .61-1.29 .53 1.43 0.81-2.51 .22




African American 1.40 1.22-1.60 <.001 1.36 1.16-1.61 <.001
Hispanic 2.60 2.29-2.86 <.001 1.11 0.91-1.36 .30
Other 1.36 1.11-1.67 .003 1.64 1.29-2.10 <.001
Cancer History
No 1.00 1.00




African American 0.90 0.34-2.35 .83 0.90 0.45-1.80 .77
Hispanic 0.99 0.58-1.67 .96 0.83 0.26-2.61 .75
Other 1.10 0.32-3.78 .88 0.22 0.04-1.09 .06
OR indicates odds ratio; CI, Confidence Interval
*Couldn't get appointment soon enough, waited too long to see the doctor, clinic/doctor's office wasn't
open, couldn't get through on the phone+
†Adjusted for sex, race/ethnicity, age, language, insurance status, income level, marital status, perceived
health status, co-morbidity, usual source of care, geographical region
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Significant differences in types of barriers by cancer type were identified. Among
all cancer types, persons with cervical cancer were more likely to report cost and
transportation barriers and those with prostate cancer were least likely to report cost
barriers and transportation barriers. There were no statistically significant associations
between organizational barriers and cancer type (Table 3.4).
Table 3.4 Barriers to Medical Care among Cancer Survivors by Cancer Site (weighted)
Site




Breast (n=790) 16.0 (13.4,19.0) 14.6 (12.1,17.4) 2.4 (1.4,3.9) 72.7
(69.4,75.7)
Cervical (n=679) 28. (24.3,32.1) 17.2 (14.4,20.4) 5.7 (3.9,8.2) 58.2
(53.9,62.3)
Colon (n=201) 12.8 (8.7,18.4) 14.3 (9.8,20.3) 5.0 (2.8,8.8) 74.6
(67.6,80.5)
Prostate (n=256) 9.0 (5.9,13.5) 9.6 (6.4,14.2) 1.5 (0.6,3.9) 83.4
(78.1,87.6)
Melanoma (n=355) 17.0 (13.1,21.7) 12.8 (9.4,17.3) 3.4 (1.8,6.4) 74.4
(69.0,79.1)
Chi-Square test with
4 df P<.001 P=.07 P=.01 p<.001
CI indicates Confidence Interval; 95% Confidence Interval
DISCUSSION
By applying the dimensions of access, I explored the impact of access barriers on
delaying or forgoing medical care.25 Findings in health services literature suggest that
costs, organizational characteristics, and transportation are critical components to the
facilitation of timely medical care.3,62,65,67,71,72 I found the presence of these barriers to be
magnified among cancer survivors. For example, survivors were more likely to report
barriers to medical care than the general population (30% vs. 15%). This is a serious
concern because of the projected growth in the number of cancer survivors in the United
States, coupled with the need for survivors to undergo routine preventive care and
follow-up services that promote quality of life and reduce risks of recurrence.1,11,17
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Moreover, since the presence of co-morbidities results in an increased need for medical
visits14, the prevalence of these barriers is especially noteworthy, given that 62.3% of
survivors reported one or more co-morbidities.
Cost Barriers - Affordability
Innovative surgical techniques and advanced clinical therapies are improving
survival rates for many types of cancers.73 These accomplishments have contributed to
escalating costs of treating the most common cancers; and consequently, many of those
costs are shared by the patient.74 The need for more frequent medical visits among
survivors also increases the likelihood for more co-payments and out-of-pocket
expenses.17,64 In this study, 88.1% of cancer survivors had either public or private
insurance and 90.7% of survivors reported a usual source of care; therefore, consistent
with prior studies, the impact of cost in delaying or forgoing care transcends insurance
status and usual source of care.62–64
In addition to escalating costs, there may be other uncalculated explanations for
survivors reporting cost as a barrier. Unfortunately, such costs cannot be ascertained
based on the NHIS survey questionnaire. The NHIS question asks participants, “Did you
delay medical care within the past 12 months because of cost?” Based on the
respondent’s perception, this question may be interpreted as: 1) direct costs associated
with treatment (e.g. I cannot afford the co-payment or I cannot afford out of pocket
expenses for uncovered services); or 2) the prohibitive cost of services that may facilitate
utilization of health services (e.g. I cannot afford to get there or I cannot afford to take
off work) commonly referred to in the literature as intangible costs.75
Within these contexts, survivors may have been more likely to report cost barriers
than the general population due to some of the possible reasons: 1) the need for more
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frequent medical visits, requiring additional out-of-pocket or cost-sharing
expenses;47,62,64 2) interruption of insurance coverage continuity;62,76 3) additional costs
associated with transportation services or child care expenses to comply with treatment a
regimen;65,76 and 4) competing financial obligations associated with meeting day-to-day
basic needs, especially among persons with low-incomes.77
The difference between cost barriers reported by African Americans and
Hispanics compared to Whites is especially noteworthy. African Americans and
Hispanics were more likely than Whites to report costs as barriers in the adjusted
interaction model. This may be the effect of greater acuity or more complex medical
conditions, requiring more medical visits.11,12,75 A greater burden of intangible costs for
these populations may be an explanation for this phenomenon. For example, persons
from communities of color may experience more travel expenses for accessing primary
or specialty care services because those services may not be available in their
neighborhoods.65,78 Future studies that tease out the impact of direct and intangible cost
barriers by racial and ethnic survivors are needed.
Psychological, socio-cultural or spiritual issues may also impact attitudes and
perceived treatment of cancer treatment modalities.79,80 These perceptions may influence
how minorities perceive value and overall affordability of health services costs.81 These
considerations are especially important since a number of researchers have found that
minorities are more likely to receive poorer quality health services, when compared to
Whites.8,81–83 Within this context, additional research is needed to examine survivors’
purchasing priorities or purchasing attitudes.
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Organizational Barriers- Accommodation
Penchansky and Thomas describe accommodation as the state in which health
services are operationally delivered in relation to meeting the client’s needs.25 In this
study, I assess this dimension based on: 1) inability to obtain a medical appointment
within a desired timeframe; 2) long wait time; 3) inconvenient hours of operation; and 4)
inability to get through on the phone. Overall, 14% of survivors reported
accommodation barriers, compared to 4% of the general population. Survivors were also
more likely to report these types of barriers in the adjusted model. This may be, in part,
due to the need for more medical visits or more frequent interactions with the healthcare
system, resulting in greater likelihood for encountering barriers.14,64
However, since Hispanics and persons from other races were more likely to report
organizational barriers in the adjusted model, there may be cultural or linguistic dynamics
that contribute to these barriers.3 For example, a number of investigations cite language
barriers, acculturation issues, employment limitations, discrimination, distrust, and
racism as culpable factors.8,84,85 Due to low response rates, I was not able to conduct an
analysis of each of the four accommodation questions; therefore, a deeper investigation
of each question is an opportunity for further exploration. This will be especially
important since more than 32 million persons are projected to obtain insurance coverage
by 2019.86
Accommodation barriers have received national attention and major initiatives are
underway. For example, funding from the Patient Protection and Affordable Care Act
has been earmarked to test the efficacy of innovative access-to-care practice models.87
Furthermore, accommodation concepts are aligned with “Superb Access to Care,” the
first domain of the Institute of Medicine’s six domains of quality.26 Established to
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promote patient-centered care and the establishment of a medical home, or usual source
of care, the Institute of Medicine describes the following as “superb access to care:” ease
of making an appointment, ability of patients to select the day and time of their
appointment, short wait times, and office hours that make primary care readily
accessible on nights, weekends, and holidays.26
Due to the importance of survivors’ obtaining routine and ongoing care, cancer
care providers may improve patient care and align with national objectives by testing
new options and integrating access-to-care best practices in their operational modalities.
Examples may include extending office hours, offering same day appointments, and
employing community health workers or patient navigators. Prior studies suggest these
strategies to be effective in increasing access and promoting continuity of care.71,72,85
Moreover, these efforts may be especially beneficial for low-wage earners who may not
have the flexibility to take off work during traditional work hours.3,77
Transportation Barriers - Accessibility
Cancer is a unique chronic disease condition, requiring highly specialized care
and frequent medical visits.1 Therefore, reliable transportation is a critical component to
patient compliance with medical appointments. While there were no significant
differences between cancer survivors and the general population in terms of
transportation barriers, noteworthy racial and ethnic disparities associated with
transportation barriers did exist, regardless of cancer survivorship.
African Americans and other races were more likely to report transportation
barriers than Whites. A plethora of research suggests that communities of color are more
likely to be medically underserved and the availability of specialized cancer care
services may be geographically inaccessible for residents of these communities.8,65,78
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Efforts to provide more convenient geographic access to cancer care services in
medically underserved communities, coupled with initiatives to promote door-to-door
transportation services for persons with cancer may help reduce the number of survivors
who delay or forgo care due to transportation. Assessing survivors’ transportation needs
should be a routine component of patient management. Medical providers can support
these needs by developing partnerships with volunteer agencies and community
resources that offer or facilitate transportation services.65
Limitations
There are several limitations to highlight. First, the NHIS questionnaire relies on
patient recall and thus survey answers may have recall bias. Second, co-morbidities are
restricted to only eleven health conditions. Third, due to low response rate, I collapse
four organizational barriers into one category. Fourth, the NHIS does not collect
information about survivors’ cancer stage, current treatment, or cancer recurrence so the
acuity levels of survivors in the sample could not be controlled in the analyses. Finally,
since the dataset includes respondents from years 2006-2010, historical effects are not
considered which may compromise external validity.
CONCLUSION
This study contributes to the body of literature by highlighting similarities and
differences in access-to-care barriers between cancer survivors and the general
population. Moreover, findings provide deeper insight into the prevalence of barriers in
both populations by race/ethnicity. National surveys, such as the NHIS and Medical
Expenditure Panel Survey, should be expanded to include questions that address
survivor attitudes and perceptions by race/ethnicity, specifically as they relate to
comprehensive access-to-care barriers. As national efforts continue to ensure access to
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medical homes for all Americans, access to a medical home is a small component of the
continuity of care continuum. Simultaneous and coordinated efforts to implement more
culturally-tailored investigations of costs, organizational and transportation barriers will
shape policy, improve delivery system designs, and ultimately promote health equity.
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CHAPTER 4:
Decomposing Differences in Medical Care Access among Cancer Survivors
by Race and Ethnicity
INTRODUCTION
The number of cancer survivors increased by 50% in the last decade, from nine
million in 2002 to 13.7 million in 2012.1,14 The incidence of cancer in 2012 alone
reached 1.6 million people and the number is projected to increase 45% by 2030 (1.6
million to 2.3 million); racial and ethnic minorities are expected to represent 28% of the
cases.88 The gravity of these statistics cannot be overlooked, realizing that racial and
ethnic disparities in treatment, outcome, and mortality continue to exist.8,10–13 This is
especially important since Hispanics are the fastest growing segment of the American
population and minorities are projected to represent the majority of the population by
2050.89
Compared to the general population, cancer survivors are more likely to report
lower perceived health status, psychological distress, poorer mental health, greater role
impairment due to emotional problems and poorer social well-being.14,19–22 Unique
medical needs include routine surveillance for primary or secondary malignancies,
monitoring chronic effects, and treatment for morbidities.17 In order to effectively
address these needs and promote quality of life, a greater level of engagement with
healthcare providers and the healthcare system is warranted.
Timely receipt of these services is paramount; however, compared to the general
population, cancer survivors are more likely to delay care because of financial and
nonfinancial barriers.63,90–92 For example, out-of-pocket costs have been documented as
a contributing factor to survivors delaying or forgoing medical care.93 The average
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annual amount of out-of-pocket expenses for newly diagnosed adult survivors is
estimated at $2,159 – more than three times the average amount the general population
spends on out-of-pocket expenses.93 These expenses can be prohibitive, especially for
persons with lower socioeconomic statuses and minorities, who are more like to be
uninsured or have public insurance.8,63,94,95
The structural design of the delivery care system also influences the likelihood of
receipt of care. Examples include but are not limited to organizational factors, such as
office hours, time to obtain an appointment, and wait time.69 This is a particularly
important issue, since persons with Medicaid and other forms of public insurance are
more likely to have a difficult time accessing providers or securing timely
appointments.8,96,97 Since minorities represent 68% of persons with Medicaid in the
United States, they are especially susceptible to these challenges.56
Access to transportation services also influences receipt of timely medical care. A
number of investigations have found racial/ethnic disparities in the ability to access
transportation services for medical treatment.65,92,98,99 For example, Guidry and
colleagues found that Hispanic survivors consistently reported barriers such as distance,
access to an automobile, and the availability of someone to drive them to the doctor as
major problems.65 Hispanic and African American respondents also identified the need
to travel farther distances for chemotherapy and radiotherapy. 65
National legislation, such as the Patient Protection and Affordable Care Act, is
expected to help increase access-to-care and promote continuity of care for cancer
survivors.100 As components of the legislation are phased in through 2019, it is important
to consider the growing numbers of minorities, coupled with greater cancer incidence
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projections over the next 20 years. Within this context, more recent, comprehensive, and
nationally representative investigations are needed to examine access-to-care barriers
across racial and ethnic populations. Furthermore, deeper analyses aimed at uncovering
contributing factors to access-to-care disparities by race/ethnicity will shape policy and
practice that will: 1) improve survivors’ quality of life, 2) help close the gap in treatment
and mortality disparities; and 3) strengthen national healthcare reform efforts.
I address this opportunity by using the Andersen Behavioral Health Model and
Penchansky and Thomas’s Dimensions of Access as a conceptual framework. First, I
examine the likelihood of cost, organizational, and transportation barriers that contribute
to delaying or forgoing medical care or treatment for Whites, African Americans and
Hispanics. Then I decompose factors to uncover predisposing, enabling, and need factors
associated with access-to-care disparities.
While a number of investigations have examined access barriers among cancer
survivors,62,63,92,94,95 this 11-year analysis contributes to the literature by: 1) examining
the magnitude of the disparity by race and ethnicity; 2) going beyond cost and
examining the magnitude of organizational and transportation barriers; and 3)
decomposing social and demographic factors that contribute to the disparities. Findings
provide insight that will support more culturally-tailored interventions and services
aimed at increasing the percentage of minority cancer survivors who receive timely
access to healthcare services.
46
Conceptual Framework
Andersen Behavioral Health Services Model - Recognized as a conceptual model
that identifies factors that facilitate utilization of health services, the Andersen Model of
Behavioral Health Services Use focuses on three dynamics: predisposing factors,
enabling factors, and need factors.23 Predisposing factors include demographic, social
characteristics or individual beliefs about health services. Enabling factors include
access to prerequisite resources and the availability of health services in the local
community. Need refers to an individual’s perceived severity of illness and
subsequently, the need for accessing health services.23
Access to Care –Described as the concept of “fit” between the patient’s needs and
the system’s ability to meet those needs, Penchansky and Thomas’s five Dimensions of
Access go beyond the traditional concepts of cost and availability.25 Availability is
defined as the relationship between need and physical availability. Accessibility captures
the relationship between location of supply and location of clients. Accommodation
refers to the state in which supply services are organized and able to meet client specific
needs. Affordability is based on the relationship of prices or fees and the clients’
perception of value. Acceptability is defined as the relationship of clients’ service
expectations compared to what is actually delivered.25,69 In this study, I examine three
outcome variables that are linked to four dimensions: Affordability, Accommodation,
Accessibility and Availability. Dependent variables are examined by race/ethnicity in the
context of barriers to medical care and treatment. Due to survey limitations, outcome
measures that explore Acceptability barriers are not explored.
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METHODS
Data from the 2000-2011 National Health Interview Survey (NHIS) were merged
and analyzed to achieve a sufficient sample size. The NHIS is based on approximately
35,500 households or 87,500 persons in the noninstitutionalized civilian population in
the United States.70 The survey is designed to track the incidence and prevalence of
illness, accidental injuries, the prevalence of chronic conditions and impairments, the
extent of disability, and the utilization of healthcare services. The NHIS survey design
includes clustering, stratification, and multistage sampling. A different sample
population is identified each year. African Americans and Hispanics are over sampled.70
Cancer survivors are defined as persons age 18-64 who reported “ever having”
any form of cancer.101 Due to sample size limitations, racial/ethnic groups are restricted
to White, African American and Hispanic. Those who reported origins of Latino or
Hispanic descent are categorized as Hispanic. The final sample size included 9,941
Whites, 1,141 African Americans, and 1,033 Hispanics.
Outcome variables
Binary variables are constructed for each of the survey questions. Three
dependent variables are explored and some questions in the survey are collapsed to
achieve a sufficient sample size.
1) Delay or forgo medical care or treatment because of cost (Affordability). This
variable includes four different questions in the NHIS survey: a) did not obtain
medications because of cost; b) did not obtain care because of cost; c) delayed care
because of cost; and d) did not obtain mental health because of cost.
2) Delay medical care because of organizational barriers (Accommodation). This
variable includes four different questions in the survey: a) delay care because doctor’s
office not open; b) delayed care because could not get through on the phone; c) delay
care because the wait is too long in the doctor’s office; and d) delay care because could
not get an appointment soon enough.
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3) Delay medical care because of lack of transportation (Accessibility).
Independent Variables
Predisposing factors include: sex, age, marital status, education, income, region,
language of interview, which served as a proxy for native language, and nativity.
Enabling factors include insurance, transportation, and source of care. Need factors
include perceived health status and comorbidities. Insurance coverage is categorized as:
no insurance, private insurance, and public insurance. Co-morbidities include 11
noncancerous conditions that typically require medical attention within the past 12
months: coronary artery disease, stroke, liver conditions, diabetes, heart conditions,
hypertension, weak or failing kidneys, arthritis, ulcer, asthma, and bronchitis. A binary
variable that equals 1 if respondents had any of the conditions and 0 otherwise is
constructed.
Data Analysis
The likelihood of experiencing unmet health needs by race and ethnicity during
the last decade is summarized. Multivariate logistic regressions are applied to estimate
the likelihood of delaying or forgoing medical care or treatment because of cost,
organizational, and transportation barriers. Race and ethnicity, and other covariates are
controlled in the regressions. Year indicators are controlled to measure aggregated
market changes over the 11-year period.
The Fairlie decomposition method (nonlinear analysis), an adaptation of the
Oaxaca-Blinder method (linear analysis) is applied.102 Using the method, the mean
differential for each dependent variable between Whites (reference) and African
Americans and Hispanics is decomposed. In order to obtain robust standard errors,
bootstrapping is conducted at 100 times simulation. The output of the model expresses
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the predicted probability for each race/ethnic group in reporting barriers. After
controlling for all covariates, the output also allows me to calculate a total explained
percentage, which represents how much of the observed characteristics are explained by
the model. Statistically significant independent variables that contribute to the disparities
are presented.
Stata 12.0 (Stata Corporation, College Station, Texas) is used for all analyses.
The NHIS is based on a number of sampling strategies, including oversampling of
racial/ethnic populations, stratification, and clustering. Stata 12.0 survey commands are
used for all analyses to account for sample weighting and the complex survey design for
correct variance estimation.
RESULTS
Table 4.1 provides characteristics of the sample population. There were 12,125
adults who reported ever having at least one or more forms of cancer: White – 9,951
(82.0%); African American – 1,143 (9.4%); Hispanic – 1,033 (8.5%). Out of the 12,125,
the majority of were women (67.2%) and 72.7% of all survivors were between the ages
of 45-64. The majority of White respondents were married (44.0%); 47.0% of African
Americans and 41.2% of Hispanics were widowed, divorced or separated. The majority
of survivors across all groups self-reported a perceived health status as good, very good,
or excellent: White – 77.0%; African American – 58.1%; Hispanic – 65.8%. African
Americans had more comorbidities (73.0%) than Whites (56.9%) and Hispanics
(58.0%). Sixty percent (60.3%) of all respondents attained education beyond high
school. The majority of White (58.0%), African American (68.0%) and Hispanics
(66.8%) reported annual incomes below $24,999. More than 90% of survivors reported a
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usual source of care. Compared to Whites, private insurance for African Americans and
Hispanics was 15.1 and 14.3 percentage points lower, respectively. The interview was
conducted in Spanish with 24.5% of Hispanics. Almost half (48.7%) of Hispanics in the
sample were not US born. Compared to Whites, African Americans and Hispanics were
more likely to report cost, organizational, and transportation barriers (p<.05). There was
a 30.5 percentage point gap between Hispanics and Whites who reported cost barriers,
53.7% vs. 23.2%, respectively. The percentage of African Americans (7.7%) who
reported transportation barriers was higher than Whites (2.8) and Hispanics (5.1%)
(p<.05).
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Delay/forgo due to cost barriers 2320(23.2) 360(31.5)* 362(53.7)*
Delay due to organizational barriers 1333(13.3) 192(16.8)* 200(19.3)*
Delay due to transportation barriers 274(2.8) 87(7.7)* 52(5.1)*
Sex
Male 3414(34.8) 328(28.8) 232(23.9)
Female 6537(65.2) 813(71.2) 801(76.1)
Age
18-24 262(2.9) 35(3.7) 46(4.4)
25-34 779(7.7) 107(9.8) 135(12.2)
35-44 1558(15.1) 168(15.9) 244(23.1)
45-54 2938(29.3) 340(29.0) 299(29.2)
55-64 4432(45.0) 493(41.6) 312(31.1)
Marital Status
Never married 1308(16.6) 308(31.0) 179(19.7)
Married 3429(44.0) 215(22.0) 332(39.1)
Widowed/divorced/separated 3266(39.4) 508(47.0) 382(41.2)
Perceived Health Status
Poor 788(7.9) 166(13.0) 130(11.7)
Fair 1525(15.3) 340(28.9) 248(22.5)
Good 2863(28.6) 355(32.3) 341(34.2)
Very good 2836(28.8) 196(18.4) 200(20.8)
Excellent 1921(19.6) 82(7.4) 112(10.8)
Comorbidity
No 4273(43.1) 304(27.0) 453(42.0)
Yes 5678(56.9) 837(73.0) 580(58.0)
Education
No degree 933(9.3) 256(22.6) 345(29.6)
High school 2646(26.3) 317(28.6) 250(23.6)
College or more 6335(64.4) 550(48.8) 436(46.8)
Income
<$24,999 4636(58.0) 685(68.0) 621(66.8)
$25,000-$54,999 2209(28.2) 202(21.2) 188(21.9)
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$55,000-$74,999 686(8.6) 44(4.8) 30(3.5)
>$75,000 422(5.2) 55(6.0) 68(7.8)
Usual Source of Care
Yes 9190(92.1) 1055(92.3) 904(87.5)
No 771(7.9) 86(7.7) 129(12.5)
Insurance
Uninsured 1018(10.2) 177(16.0) 235(21.5)
Public 4354(39.9) 585(49.2) 471(42.9)
Private 4579(49.9) 379(34.8) 327(35.6)
US Region
West 1684(18.2) 148(13.6) 165(17.8)
Northeast 2541(25.5) 260(23.6) 88(9.3)
North Central/Midwest 3574(36.2) 621(55.1) 381(37.1)
South 2152(20.1) 112(7.7) 399(35.8)
Interview Language
English 9910(99.9) 1137(100) 742(75.5)
Spanish or other 7(<.01) - 289(24.5)
Nativity
US Born 9654(97.0) 1092(95.7) 526(52.3)
Non US born 293(2.9) 49(4.3) 500(48.7)
Note: n=12.125 –categories may not equal due to missing values; * = p<.05 using independent
t-tests; Data Source: National Health Interview Survey, 2000-201
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To determine the overall percentage of survivors by race and ethnicity who did
not receive timely care due to all of the barriers combined, three outcome measures are
collapsed into one dummy variable. Trends were assessed by plotting percentages by race
and ethnicity over the 11-year period (Figure 4.1). Findings illustrate a modest increase in
the percentages of minority survivors who reported barriers over the 11-year period. The
11-year percent average of those who did not receive timely care due those barriers was
highest among Hispanics (42.0%) followed by African Americans (39.4%) and Whites
(32.5%).
Multivariate Regression and Decomposition Results
Table 4.2 displays the adjusted model of cancer survivors who did not receive
timely care due to cost, organizational and transportation barriers. Adjusted odds ratios
for each independent variable by race and ethnicity are presented and reported at a 95%
confidence interval. The model controls for all independent variables, including year.
Cost Barriers
There were no statistically significant findings in cost barriers between Whites
and minorities (Table 4.2). Compared to those between the ages of 18-24, survivors
between the ages of 55-64 were least likely to delay care because of cost (OR 45; p
<.001). Widowed, divorced or separated survivors were also more likely to report cost
barriers (OR 1.48 p<.001) compared to those who were never married (reference). There
was also a negative correlation between perceived health status and likelihood to delay
care or treatment because of cost – the better the perceived health, the less likely to delay
or forgo. Survivors with comorbidities and no usual source of care were also more likely
to delay or forgo health services due to cost (OR 1.41, OR 2.55; p<.001, respectively).
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Compared to those who were uninsured, survivors with private and public insurance were
less likely to delay (OR .27 p<.001; OR .38 p<.001 respectively). Residents of the
Western region were least likely to delay care because of cost compared to residents of
other regions. There were also significant findings in the likelihood for survivors to
delay care due to cost in years 2004-2005 (consecutively) compared to 2000 (reference)
Table 4.3 presents the results of the decomposition model. The top panel presents
the results of the predicted likelihood of delaying/forgoing any care for each
race/ethnicity group, the differences in the predicted likelihood and the percentages of the
disparities can be explained by the model. The bottom panel lists individual factors
associated the disparities. These decomposition estimations controlled for all explanatory
variables. For brevity purposes, variables that are significantly associated with racial and
ethnic disparities in healthcare access are reported.
The predicted probability of delaying care or treatment due to cost was .29 for
Whites, .35 for African Americans and .40 for Hispanics. The observed differences in
cost barriers explain 99% of disparities in African Americans and 34% of disparities in
Hispanics when compared to Whites. Insurance and perceived health were significant
explanatory variables associated with cost disparities among African Americans and
Hispanics. Comorbidity was an explanatory variable that was unique for African
Americans and age, nativity and year were significant factors for Hispanics.
Organizational Barriers
Hispanics were more likely to delay care due to organizational barriers (OR 1.38
p<.05) than Whites (reference) (Table 4.2). There were also negative correlations
between the survivors’ age and likelihood to delay because of organizational barriers –
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the younger the survivor, the greater the likelihood to delay. Consistent with cost
barriers, the better the perceived health, the less likely to delay or forgo because of
organizational barriers. Persons with comorbidities (OR 1.48 p<.001) and public
insurance (OR 1.40 p<.001) were also more likely to delay care due to organizational
issues. Survivors who reside in the South (OR 1.46 p<.001) were also more likely to
report organizational barriers, compared to those who reside in the west (reference).
Year 2011 was the only year in which survivors were more likely to delay due to
organizational barriers (OR 1.44 p<.05); 2000 (reference).
The predicted probability of delaying care due to organizational barriers was .14
for Whites, .18 for African Americans and .22 for Hispanics. The decomposition model
explained 53% of the observed differences in the African American population. Private
insurance and perceived health status were key factors associated with the disparity in
African Americans. While the model explained 13% of the organizational access
disparities in Hispanics, there were no significant findings.
Transportation Barriers
Compared to Whites, African Americans were more likely to delay care due to
transportation (OR 1.54 p<.001) (Table 4.2). Widowed, separated or divorced survivors
were more likely to delay due to transportation than those were never married (OR 1.39
p<.05). Consistent with cost and organizational barriers, I found a negative correlation
between perceived health status and likelihood to delay because of transportation - the
better the perceived health, the less likely to delay or forgo because of transportation.
Survivors with comorbidities (OR 1.63 p<.001) and public insurance (OR 1.87 p<.001)
were also more likely to experience transportation barriers while those with private
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insurance were least likely (OR .35 p<.001). Year 2009 was the only year in which
survivors were more likely to experience transportation barriers (OR 2.12 p<.05)
compared to 2000 (reference).
The predicted probability of delaying care due to transportation was .03 for
Whites, .09 for African Americans and .06 for Hispanics (Table 4.3). The transportation
decomposition model explained 58% of the observed differences in African Americans
and 82% of the observed differences in Hispanics. Perceived health was the only factor
associated with the disparity between Whites and African Americans. The model could
not explain significant contributing factors to transportation access disparities in the
Hispanic population.
Table 4.2 Adjusted Model: Cancer Survivors who Delay or Forgo Medical Care due to Cost,




















White 1.00 (ref) 1.00(ref) 1.00(ref)
African American 0.92 0.34 1.01 0.83 1.54 0.00
Hispanic 1.24 0.06 1.38 0.01 1.45 0.19
Age
18-24 1.00(ref) 1.00(ref) 1.00(ref)
25-34 1.23 0.19 0.84 0.42 0.45 0.02
35-44 1.00 0.06 0.70 0.05 0.54 0.05
45-54 0.79 0.14 0.55 0.00 0.35 0.00
55-64 0.45 0.00 0.46 0.00 0.28 0.00
Marital Status
Never married 1.00(ref) 1.00(ref) 1.00(ref)
Married 0.67 0.00 0.89 0.30 0.71 0.13
Widowed/divorced/
separated 1.48 0.00 0.94 0.54 1.39 0.05
Perceived Health
Poor 1.00(ref) 1.00(ref) 1.00(ref)
Fair 0.69 0.00 0.88 0.28 0.69 0.02
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Good 0.45 0.00 0.75 0.01 0.22 0.00
Very Good 0.27 0.00 0.57 0.00 0.16 0.00
Excellent 0.16 0.00 0.41 0.00 0.13 0.00
Comorbidity
No 1.00(ref) 1.00(ref) 1.00(ref)
Yes 1.41 0.00 1.48 0.00 1.63 0.00
Education
No degree 1.00(ref) 1.00(ref) 1.00(ref)
High School/GED 1.03 0.69 1.05 0.62 0.84 0.29
Some College or more 1.06 0.73 1.30 0.01 0.76 0.09
Usual Source of Care
Yes 1.00(ref) 1.00(ref) 1.00(ref)
No 2.55 0.00 0.92 0.50 1.10 0.68
Insurance
No insurance 1.00(ref) 1.00(ref) 1.00(ref)
Public insurance 0.38 0.00 1.40 0.00 1.87 0.00
Private insurance 0.27 0.00 .94 .51 0.35 0.00
Language
English 1.00(ref) 1.00(ref) 1.00(ref)
Spanish or other 0.81 0.34 0.71 0.16 0.51 0.18
US Region 1.00(ref) 1.00(ref) 1.00(ref)
West
Northeast 1.23 0.02 1.17 0.16 0.96 0.85
North/Central/Midwest 1.23 0.01 1.13 0.23 0.91 0.62
South 1.41 0.00 1.46 0.00 1.15 0.50
Nativity
US Born 1.00(ref) 1.00(ref) 1.00(ref)
Non US Born 0.89 0.47 1.08 0.64 0.67 0.46
Years
2000 1.00(ref) 1.00(ref) 1.00(ref)
2001 1.02 0.90 1.14 0.50 1.38 0.34
2002 0.94 0.73 1.21 0.34 1.06 0.86
2003 1.10 0.55 0.87 0.52 1.10 0.78
2004 2.45 0.00 1.16 0.42 1.34 0.39
2005 2.83 0.00 1.24 0.24 1.59 0.16
2006 3.36 0.00 1.28 0.21 1.39 0.36
2007 2.54 0.00 1.11 0.57 0.82 0.62
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2008 3.05 0.00 1.35 0.11 1.07 0.85
2009 2.92 0.00 1.43 0.05 2.12 0.03
2010 3.37 0.00 1.27 0.19 1.72 0.09
2011 2.95 0.00 1.44 0.04 1.72 0.09
Notes: Data Source: National Health Interview Survey 2000-2011; Adults ages 18-64; OR = Odds Ratio
Table 4.3: Decomposition Results for Barriers to Care by Race/Ethnicity
Cost Barriers Organizational Barriers Transportation Barriers
White(ref)












Predicted Value .35 .40 .18 .22 .09 .06















Age - .01 - - - -
Public Insurance -.03 -.03 - - - -
Private
Insurance .03 .04 -.02 - - -
Perceived Health .03 .01 .02 - .02 -
Comorbidity .01 - - - - -
Nativity - .03 - - - -
Year - .01 - - - -
Notes: Data source - National Health Interview Survey 2001-2011. Non-significant results are excluded for each
decomposition. All regression models include year fixed effects. Positive/negative coefficients indicate the share of
explanatory variables that are positively/negatively associated with forgoing or delaying care. The share of observed




By using the Dimensions of Access as a framework, this study contributes to the
literature by dissecting three access-to-care dimensions and examining disparities in
explanatory variables between White and minority cancer survivors. Findings show that
affordability (cost barriers), accommodation (organizational barriers), and
availability/accessibility (transportation barriers) negatively impact survivors’ ability to
obtain timely medical care and treatment. Furthermore, compared to Whites, the
predicted probability of encountering those barriers was consistently greater for African
American and Hispanic survivors.
Insurance was an enabling factor that contributed to disparities in preventing or
delaying care due to cost in African Americans and Hispanics. The negative public
insurance coefficients suggest that African Americans and Hispanics are not as likely to
experience cost barriers when they have access to public insurance. Furthermore, the
disparity in delaying care due to cost can be explained by minorities having
disproportionate access to private insurance when compared to Whites.
Through Medicaid expansion and health insurance exchanges, the provisions of
the Patient Protection and Affordable Care Act (PPACA) will help close the gap in
delaying care or treatment due to costs.100,103 However, findings suggest that increasing
access to public and insurance alone will only partially address the disparity. Enabling
factors, such as transportation and organizational barriers play a key role.65,71 According
to the adjusted model, minority survivors with public insurance were more likely to
delay care due to transportation barriers and African American survivors, in general,
were more likely to experience transportation challenges. A number of investigations
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provide insight into the causes of this phenomena: 1) Communities of color are more
likely to be medically underserved, requiring patients to travel farther distances for
primary care, specialty care, prescriptions and support services.78,104,105 2) Primary care
physicians may be less likely to accept patients with Medicaid or other forms of public
insurance, requiring them to travel farther distances.106–109 3) Minorities are also more
likely to seek racially and linguistically concordant medical providers.8,83,110–112 These
preferences, coupled with national shortages of minority providers, may contribute to
increased travel time and associated expenses.8,83,113 Policies and patient management
practices that acknowledge the relevance of these factors in facilitating care should be
supported and implemented.
Lewin-Epstein (1991) describes a usual source of care as the patient’s entry point
into a complex and bureaucratic healthcare system that promotes continuity and links
patients to specialty care and other support services.114 These findings corroborate the
relationship between a usual source of care and reporting cost as a barrier. Survivors
without a usual source of care were 2.5 times more likely to report cost as a barrier.
Therefore, there are opportunities to close the gap in cost barriers by implementing
comprehensive efforts to increase the number of survivors with a usual source of care.
In the wake of national efforts to increase access to a usual source of care, timely
receipt of care will rely upon convenient and more responsive access to medical
providers. Ease of obtaining an appointment soon, hours of operation, wait times and
other patient-centered factors are relevant factors for increasing access-to-care for
minority populations.115 Deficiencies in these areas can cause consumers to lose access to
a usual source of care provider, resulting in exacerbation of medical conditions.68
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Compared to Whites, Hispanic survivors were more likely delay care due to
organizational barriers. Findings also suggest nativity as a contributing factor to cost
related barriers between White and Hispanics. Unobserved factors, such immigration
status, complex or confusing health policies or procedures, and limited orientation to a
system of care also contribute to organizational access barriers.8,84,85,115
One strategy that has been effective in breaking down many of these barriers has
been the inclusion of patient navigators as members of the cancer care team. Patient
navigators serve as patient advocates whose duties include but are not limited to: helping
patients secure timely medical appointments, promoting effective communicate with
providers, troubleshooting and resolving psychosocial barriers that impede care, and
completing entitlement applications.84,85,116 Cancer care providers should take advantage
of patient navigator demonstration projects funded by the Department of Health and
Human Services as part of the Patient Protection and Affordable Care Act.117 Providers
may also consider employing navigators or developing linkages with organizations that
employ navigators. These efforts will improve access to timely and appropriate care,
help retain persons in care, and ultimately reduce or eliminate racial and ethnic cancer
mortality disparities.
It is clear that the current capacity of the nation’s healthcare system cannot
support the 32 million Americans expected to benefit from expanded coverage; 13
million of whom are projected to be Medicaid beneficiaries.118 Again, these projections
are especially relevant since persons with Medicaid were more likely to encounter
organizational barriers even when other predisposing, enabling and need factors are
controlled. While the ACA does include funding initiatives that address these issues,
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there are opportunities for surveillance and future research to examine how minority
cancer survivors and those with Medicaid fare during and post ACA implementation.
Perceived need is explored by including perceived health and comorbidity in the
decomposition model. Perceived health was a significant explanatory variable in the cost
model for African American and Hispanic survivors. The difference is likely due to
poorer health status associated with higher acuity and comorbidities that may have been
exacerbated by underinsurance, resulting in the absence of preventive care.10,12,13,94
Cormorbidity was attributable to the disparity in Hispanics. Again, this may be the result
of a higher population of Hispanics with complex or exacerbated cancerous conditions
caused by delaying or forgoing care over time.8,59
Based on the 11-year analysis, consecutive annual trends in the likelihood of
survivors to delay care or treatment from years 2004-2011 were found. This finding is
noteworthy since adjusted odds ratios range from 2.45(p<.001) to 3.37(p<.001) compared
to 2000 (reference). Since this time period overlaps with the Great Recession of 2007-
200930, findings corroborate prior investigations that have found a downward trend in
health services utilization across racial and ethnic populations during the recession.31,33
Furthermore, African American survivors in the North/Central/Midwest, Northeast, and
Southern regions of the United States and Hispanics in the South may have been
especially burdened by the recession.
As a result of these findings, thousands of survivors delayed or forwent medical
care. Comprehensive efforts that are culturally and linguistically appropriate should be
underway to help survivors understand the ACA, their respective entitlements, as well as
various modalities for enrollment and accessing services. These types of initiatives will
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be instrumental for re-orienting survivors to the healthcare system and promoting
continuity of subsequent care.
Limitations
There are several limitations to highlight. First, the NHIS questionnaire relies on
patient recall and thus survey answers may have recall bias. Second, co-morbidities were
restricted to only eleven health conditions. Third, in order to achieve a sufficient sample
size, anyone who reported one or more forms of cancer were collapsed into one dataset.
Therefore, access-to-care barriers could not be analyzed by cancer type. Fourth, the
NHIS did not collect respondent’s type of community during the time period (i.e. rural,
metropolitan, suburban); therefore, transportation barrier by type of community could
not be analyzed. Fifth, due to low response rates, four unique questions were categorized
into “delaying or forgoing medical care or treatment because of cost” and four unique
questions were categorized as “delaying medical care due to organizational barriers.”
Therefore, trends in responses by the eight individual questions could not be assessed.
Sixth, the NHIS questions do not specifically ask if delayed care was directly related to
cancer care services; therefore, it cannot be assumed that reported delays were directly
associated with cancer treatment or services that facilitate treatment. Finally, the NHIS
does not collect information about survivors’ cancer stage, current treatment, or cancer




Unraveling the multidimensional components of access-to-care are prerequisites
for improving quality of care at all phases of the cancer care continuum. Consequently, a
multifaceted approach is necessary for improving cancer survival rates and closing the
gap in racial/ethnic health outcome disparities. Research, policies, and operational
practices that go beyond insurance are needed to promote timely access to cancer care
services. Executing these efforts within the context of the unique needs of minorities,
persons with low incomes and Medicaid beneficiaries will help close the disparity gap in
access, morbidity and mortality. Furthermore comprehensive efforts are needed to
ensure survivors understand the ACA and how they may benefit. Collectively, these




The purpose of this study was to examine racial and ethnic differences in access
to timely cancer screening and treatment services for a growing number of cancer
survivors. In light of healthcare reform efforts, the findings of this study provide key
considerations for practice, policy and future research. Collectively, these
recommendations, which go beyond the Affordable Care Act, will help: 1) increase the
percentages of women screened for breast and cervical cancers; 2) decrease cancer-
related mortality by promoting early detection and ensuring timely access to care for
survivors; and 3) reduce or eliminate racial and ethnic disparities in cancer treatment and
health outcomes.
Practice
Language and nativity, a proxy for acculturation, were identified as characteristics
associated with lower screening rates and delayed access to care due to cost. For
example, women who did not speak English as a primary language were less likely to
receive a mammogram and nativity was one of the leading factors attributed to the
disparity in delaying care due to cost between Whites and Hispanics. Furthermore,
Hispanics were more likely to delay care due to organizational barriers than Whites.
Linguistic barriers, confusing policies or procedures, unavailability of evening or
weekend hours, and culturally insensitive practices may be root causes.
Cancer care providers can address these issues by taking proactive measures to
create and sustain a system of care that is culturally and linguistically tailored to meet the
needs of the populations they serve. Evidence-based practices are needed to help persons
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who do not speak English as a primary language and those who are not born in the United
States, understand their rights as citizens and consumers. Since immigrants cannot access
Medicaid until they have been in the United States for at least five years, cancer care
providers can establish linkages with federally qualified health centers and other safety
net providers to ensure that survivors have access to critical medical and psychosocial
services.
Providing nontraditional access to medical appointments and testing new
appointment models may also help reduce access to care disparities. For example,
expanding office hours to include nights and weekends, offering same-day access to
medical appointments, and ensuring patients can get through on phone the during the first
attempt may be effective. Since patients with cancer are likely to miss work due to
medical appointments or lose their jobs due to missed work, these new models may also
contribute to survivors’ ability to sustain employment.
Low-income communities and communities of color are more likely to be
medically underserved. These shortages result in survivors traveling longer distances for
care. Longer distances may require multiple transportation modalities, resulting in
increased costs, especially in urban communities (i.e. car, bus, train, taxi). Although there
are provisions in the Affordable Care Act to increase the availability of primary care and
specialty care in underserved communities, cancer care cancer providers can take
immediate actions to address transportation challenges. For example, assessing a patient’s
transportation needs can be routine and integrated as part of the patient’s overall plan of
care. Providers can also develop community-based partnerships with transportation
agencies. For example, cancer care providers can collaborate with transportation
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providers and develop memoranda of understanding to offer door-to-door transportation
services for patients. Developing driver volunteer programs may also be a viable option,
particularly for rural communities or for those with compromised immune systems.
While these initiatives can help increase access to timely medical care, they can also
benefit the medical provider by reducing no-show rates.
During the recession period, breast and cervical screening rates dropped. As the
economy rebounds and as components of the ACA are phased in, women who have
forgone screening should be targeted and re-engaged in care. Educational and awareness
campaigns should emphasize that ACA regulations prohibit insurers from imposing cost
sharing requirements on preventive screening measures such as breast, cervical and
colorectal screening. Concentrating these efforts in the Midwest, South and West may be
most effective in improving national screening rates and achieving Healthy People 2020
screening targets.
Policy
From the ACAs no-cost screening provisions to expanded health insurance
coverage, the country is making progress in the area of prevention. However, there are
still policy-relevant opportunities. National efforts are needed to create and sustain
systems of care that are culturally and linguistically sensitive. For example, the United
States Office of Minority Health’s Culturally and Linguistically Appropriate Standards
can be enforced by the Centers for Medicare and Medicaid to ensure that all providers
that receive federal funds or reimbursements have operations that reflect the standards. In
addition, organizational and licensing or certification entities can include these standards
as criteria for organizational performance expectations and professional competency
standards. Collectively, these accomplishments will help cancer care providers engender
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more sensitive practices that will help close the gap in racial and ethnic access-to-care
disparities.
Since its inception in 1991, the National Breast and Cervical Cancer Early
Detection Program, has screened more than 10.4 million women across the country.
Furthermore, more recently, culturally-tailored evidence-based practices have been
implemented to increase access to this program for a rapidly growing Hispanic
population. These efforts may explain why screening rates improved among Hispanic
women during the recession period. As a result of its effectiveness, funding
appropriations for the program should remain level until cancer screening utilization
effects of the ACA can be explored; and due to the reduction in breast and cervical
screening during the recession period, the federal government and other national
stakeholders should prioritize screening resources to target residents of the South and
Midwest.
According to the decomposition model, increasing the number of African
Americans and Hispanics with public insurance, will help close the disparity in access-to-
care due to cost. While there is a provision in the ACA to incentivize providers to accept
those with Medicaid, some providers may still place caps on the number of persons they
treat with Medicaid due to the administrative burden. Whether they choose to participate
in Medicaid expansion or not, states should develop policies and procedures to reduce the
administrative burden imposed on medical providers who see patients with Medicaid.
The alleviation of cumbersome procedures will increase access-to-care and have a
favorable impact on minority cancer survivors.
69
Future Research
The results of this study offer opportunities for a variety of future investigations.
For example, due to National Health Interview Survey limitations, access barriers that are
related to the Acceptability dimension of access could not be explored. Uncovering these
barriers will help health services researchers and practitioners better understand
unobserved factors that could not be explained by the decomposition model. Therefore,
expanding the access to care section of the survey to include questions related to patients’
preferences and their providers’ ability to meet those preferences will be helpful; for
example, “I delayed care because no one could speak my language” or “I delayed care
because I was mistreated during my last visit.” Delaying care due to child care or because
of the inability to take off work should also be explored. Access to this information will
help health services researchers develop future studies that will inform practice and
policy.
Increasing the number of adults screened for colon cancer between 50 and 75
years old is also a Healthy People 2020 goal; however, due to the USPTF’s five and ten
year screening intervals for sigmoidoscopy and colonoscopy, respectively, more time
needs to elapse before data are available. Therefore, future research is needed to explore
trends in colon cancer screening rates by race and ethnicity before and during the Great
Recession. Findings will help identify socio-demographic and geographic populations to
target for screening and re-engagement in preventive health services.
In order to obtain a sufficient size of survivors in Chapters 3 and 4, I collapsed
those with a history of cancer into one population. Therefore, I could not analyze the
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likelihood of encountering barriers by cancer type. More research is needed to examine
trends in encountering barriers by cancer type.
And finally, more than 32 million Americans are expected to gain health
insurance through ACA provisions. This translates into an influx of persons entering a
system of care with an already overwhelmed primary and specialty care capacity.
Although the ACA includes initiatives to address these shortages, future investigations
will be needed to assess the impact of survivors forgoing care due to organizational
barriers in this new climate.
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